Dr. Lataillade brings over two decades of in-depth research experience to the CytoDyn team, with robust expertise investigating novel drug products and therapies. He most recently served as Vice ...

GlaxoSmithKline’s ViiV Healthcare joint venture is developing an injectable pre-exposure prophylaxis (PrEP) which can prevent permanent HIV infection According to Reuters, ViiV, a joint venture ...

This project is now archived, all future development is now on our new python installer which has more features etc. See the new project here: https://github.com ...

The company has a new logo, designed by Pentagram, that looks incredibly plain — especially compared to previous iterations of the logo that featured a rakish slant, two shades of blue ...